USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Boehringer Ingelheim Pharma GMBH & Co. KG

USPTO PatentsView assignee record - 11 granted patents across 9 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

RSS updates for this company

The verdict

According to USPTO PatentsView, Boehringer ranks #24,011 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 9 technology areas.

#24,011
of 49,997 US assignees by volume
Top 47%
by Innovation Score (36.1/100)
17.1
avg claims per patent
-90%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R24011 · Foreign Corporation #24,011 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 11 grants
  • MID-PACK #24,011/49,997
  • PHOTO-FINISH Blue Tomato
  • CPC-NARROW A61M · 9 areas
  • INNOV-THIN 36.1/100
  • CLAIMS-RICH 17.1 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -90% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Blue Tomato, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Boehringer’s 36.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Boehringer

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Boehringer's Innovation Score is 36.1/100 (top 47% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Boehringer?

Each dot is one of Boehringer’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Boehringer’s own 17.1 claims/patent is ABOVE the 15.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Boehringer vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 10.910.91111.1 05101520 Granted patents (volume) Avg claims / patent Blue Tomato, LLC - 11, 16.64Blue TomatoBluedot Innovation PTY Ltd. - 11, 16.91Bluedot Innovatio…BNL Eurolens - 11, 16.55BNL EurolensBobst Firenze S.R.L - 11, 15.64Bobst Firenze S R…Boewe Systec GMBH - 11, 17.18Boewe SystecBoolabox, Inc. - 11, 1BoolaboxBoreskov Institute OF Catalysis - 11, 15.55Boreskov Institut…Bormioli Pharma S.P.A. - 11, 10.55Bormioli Pharma S…Boehringer Ingelheim Pharma GMBH & Co. KG - 11, 17.09Boehringer Ingelh…
Boehringer vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Boehringer's grants concentrate

Boehringer Ingelheim Pharma GMBH & Co. KG is a focused PatentsView assignee: 9 CPC subclasses with 45.5% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2015 (6 grants) versus a trough of 1 in 2017. By volume, Boehringer sits between Blue Tomato, LLC and Bormioli Pharma S.P.A..

Boehringer's three-year grant acceleration

Boehringer Ingelheim Pharma GMBH & Co. KG shows 1 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Boehringer's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Boehringer holds 11 patents at rank #23,974, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Boehringer

By rank, the assignees closest to #23,974 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Boehringer's primary technology class.

Boehringer's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 47% higher than 53% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 20152016201720182023 1
USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Boehringer Ingelheim Pharma GMBH & Co. KG patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 6 54.5%
2016 2 18.2%
2017 1 9.1%
2018 1 9.1%
2023 1 9.1%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Boehringer Ingelheim Pharma GMBH & Co. KG's patent record in context - here's where to go next.

  • Boehringer Ingelheim Pharma GMBH & Co. KG's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 45.5% of its portfolio - see every assignee active in that class. Explore A61M
  • Ranked #24,011 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Boehringer Ingelheim Pharma GMBH & Co. KG against Blue Tomato, LLC, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 36.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.